Commission Regulation (EU) No 175/2014 of 25 February 2014 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health Text with EEA relevance
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
1. The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006. 2. However, the health claims referred to in paragraph 1 used prior to the entry into force of this Regulation, may continue to be used for a maximum period of six months after the entry into force of this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Rejected health claims Application – Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data A combination of B. longum LA 101, L. helveticus LA 102, L. lactis LA 103 and S. thermophilus LA 104 Improves intestinal comfort Q-2012-00588 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data A combination of B. longum LA 101, L. helveticus LA 102, L. lactis LA 103 and S. thermophilus LA 104 Regulates your (intestinal) transit Q-2012-00589 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data ♀EFAX™ ♀EFAX™ contributes to maintain a normal menstruation cycle Q-2012-00591 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Slendesta® Potato Extract Slendesta® contributes to the reduction of body weight in overweight individuals Q-2012-00704 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Monurelle® Proanthocyanidins from Monurelle® may help to support defence against bacterial pathogens in the lower urinary tract Q-2012-00737 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Vichy Catalan carbonated natural mineral water Vichy Catalan, a bicarbonated natural mineral water rich in mineral salts, contributes to reduce blood triglycerides rise during digestion Q-2012-00872
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.